Zenas Biopharma Inc (ZBIO) Unusual Options Activity Today

Checking ZBIO unusual options activity helps you spot when traders are making outsized bets on Zenas Biopharma Inc before the broader market catches on. Zenas Biopharma Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ZBIO unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ZBIO unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ZBIO unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ZBIO unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody.

Zenas BioPharma, Inc. was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is based in Waltham, Massachusetts.

Catalysts rarely arrive without a footprint, and ZBIO unusual options activity is often where that footprint shows up first. Our scanner tracks Zenas Biopharma Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ZBIO unusual options volume on the call side or chasing put sweeps, Zenas Biopharma Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.